The Cancer Research Technology Pioneer Fund (CPF) today (Friday) has announced a collaboration with the Cancer Research UK Manchester Institute Drug Discovery Unit, at The University of Manchester, to develop a promising class of drugs called RET inhibitors to treat cancer.
» more
No comments:
Post a Comment